TRCT
BLUE

Tower Research Capital (TRC)’s bluebird bio BLUE Stock Holding History

Tower Research Capital (TRC)’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,421
Closed -$11.8K – 5268
2025
Q1 		$11.8K Sell
2,421
-656
-21% -$3.94K ﹤0.01% 3499
2024
Q4 		$25.7K Buy
3,077
+2,322
+308% +$20.3K ﹤0.01% 2997
2024
Q3 		$7.86K Sell
755
-1,181
-61% -$19.6K ﹤0.01% 4010
2024
Q2 		$38.1K Buy
1,936
+1,871
+2,878% +$37.5K ﹤0.01% 3302
2024
Q1 		$1.65K Sell
65
-2,177
-97% -$55.8K ﹤0.01% 5217
2023
Q4 		$61.9K Buy
2,242
+1,169
+109% +$71.3K ﹤0.01% 2988
2023
Q3 		$65.2K Sell
1,073
-85
-7% -$5.97K ﹤0.01% 2325
2023
Q2 		$76.2K Buy
1,158
+155
+15% +$11.3K ﹤0.01% 2246
2023
Q1 		$64K Sell
1,003
-1,606
-62% -$183K ﹤0.01% 2277
2022
Q4 		$361K Sell
2,609
-43
-2% -$6.06K 0.02% 902
2022
Q3 		$336K Buy
2,652
+1,329
+100% +$150K 0.01% 1452
2022
Q2 		$110K Buy
1,323
+725
+121% +$56.2K ﹤0.01% 2205
2022
Q1 		$58K Sell
598
-199
-25% -$26.3K ﹤0.01% 2607
2021
Q4 		$159K Sell
797
-131
-14% -$30.9K ﹤0.01% 1929
2021
Q3 		$230K Buy
928
+671
+261% +$192K 0.01% 1684
2021
Q2 		$107K Sell
257
-1,211
-82% -$480K ﹤0.01% 2365
2021
Q1 		$573K Buy
1,468
+197
+15% +$97K 0.01% 1120
2020
Q4 		$713K Buy
1,271
+968
+319% +$613K 0.02% 725
2020
Q3 		$212K Buy
303
+55
+22% +$42.9K ﹤0.01% 2524
2020
Q2 		$197K Buy
248
+244
+6,100% +$184K 0.01% 1800
2020
Q1 		$3K Sell
4
-38
-90% -$37K ﹤0.01% 2444
2019
Q4 		$47K Buy
+42
New +$45.7K ﹤0.01% 1374
2019
Q3 		– Sell
-63
Closed -$103K – 4092
2019
Q2 		$103K Buy
63
+30
+91% +$51.9K 0.01% 1165
2019
Q1 		$68K Buy
33
+32
+3,200% +$56.3K ﹤0.01% 1611
2018
Q4 		$1K Sell
1
-6
-86% -$9.2K ﹤0.01% 3550
2018
Q3 		$14K Sell
7
-92
-93% -$190K ﹤0.01% 2545
2018
Q2 		$201K Buy
+99
New +$226K 0.01% 1065
2017
Q4 		– Sell
-283
Closed -$504K – 3528
2017
Q3 		$504K Buy
+283
New +$395K 0.04% 256
2017
Q1 		– Sell
-274
Closed -$219K – 3082
2016
Q4 		$219K Buy
274
+263
+2,391% +$209K 0.02% 598
2016
Q3 		$9K Buy
+11
New +$7.97K ﹤0.01% 2116
2016
Q1 		– Sell
-8
Closed -$6K – 4132
2015
Q4 		$6K Sell
8
-135
-94% -$135K ﹤0.01% 2733
2015
Q3 		$159K Buy
143
+51
+55% +$93K 0.02% 353
2015
Q2 		$201K Buy
92
+19
+26% +$38.7K 0.02% 370
2015
Q1 		$115K Buy
73
+59
+421% +$77.8K 0.01% 767
2014
Q4 		$17K Buy
+14
New +$9.36K ﹤0.01% 1700
2014
Q3 		– Sell
-24
Closed -$12K – 4429
2014
Q2 		$12K Sell
24
-26
-52% -$8.34K ﹤0.01% 2195
2014
Q1 		$15K Sell
50
-37
-43% -$11.2K ﹤0.01% 2160
2013
Q4 		$24K Buy
87
+66
+314% +$18.4K ﹤0.01% 2112
2013
Q3 		$7K Buy
+21
New +$7.8K ﹤0.01% 3427

Other funds holding BLUE

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Tower Research Capital (TRC)'s BLUE Position: Q2 2025 in Review

Tower Research Capital (TRC) sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 2,421 shares — an estimated $11.8K sold.

Tower Research Capital (TRC) first reported a position in BLUE in Q3 2013 and held it in 39 quarters. The position peaked at $713K in Q4 2020. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Tower Research Capital (TRC) reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,421 bluebird bio shares in Q2 2025, an estimated $11.8K.
  • Tower Research Capital (TRC) first reported a position in bluebird bio in Q3 2013 and held it in 39 quarters.
  • Tower Research Capital (TRC)'s bluebird bio position peaked at $713K in Q4 2020.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.